Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Potthoff

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|June 25, 2015
Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY RegistryRoland E Schmieder, Sebastian A Potthoff, Peter Bramlage, et al.
British Journal of Pharmacology|March 5, 2011
Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient miceJ Stegbauer, S A Potthoff, I Quack, et al.
Lancet (London, England)|March 11, 1998
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study GroupD W Cameron, M Heath-Chiozzi, S Danner, et al.
The Journal of Biological Chemistry|February 16, 2011
PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemiaIvo Quack, Magdalena Woznowski, Sebastian A Potthoff, et al.
Journal of Viral Hepatitis|October 21, 2006
Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapyA Potthoff, H L Tillmann, C Bara, et al.
HIV Medicine|May 24, 2021
Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general populationC-A Schulz, L Mavarani, N Reinsch, et al.
Primary Care Diabetes|January 17, 2026
SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in GermanyL Hilgefort, A Potthoff, S Nambiar, et al.
Regulatory Peptides|July 16, 2011
PTH-receptors regulate norepinephrine release in human heart and kidneyS A Potthoff, A Janus, H Hoch, et al.
Frontiers in Public Health|September 12, 2022
HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in GermanyM Uhrmacher, A Skaletz-Rorowski, S Nambiar, et al.
Hypertension (Dallas, Tex. : 1979)|November 6, 2013
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient miceSebastian A Potthoff, Michael Fähling, Tilman Clasen, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Hypertension (Greenwich, Conn.)|June 25, 2015
Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY RegistryRoland E Schmieder, Sebastian A Potthoff, Peter Bramlage, et al.
British Journal of Pharmacology|March 5, 2011
Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient miceJ Stegbauer, S A Potthoff, I Quack, et al.
Lancet (London, England)|March 11, 1998
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study GroupD W Cameron, M Heath-Chiozzi, S Danner, et al.
The Journal of Biological Chemistry|February 16, 2011
PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemiaIvo Quack, Magdalena Woznowski, Sebastian A Potthoff, et al.
Journal of Viral Hepatitis|October 21, 2006
Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapyA Potthoff, H L Tillmann, C Bara, et al.
HIV Medicine|May 24, 2021
Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general populationC-A Schulz, L Mavarani, N Reinsch, et al.
Primary Care Diabetes|January 17, 2026
SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in GermanyL Hilgefort, A Potthoff, S Nambiar, et al.
Regulatory Peptides|July 16, 2011
PTH-receptors regulate norepinephrine release in human heart and kidneyS A Potthoff, A Janus, H Hoch, et al.
Frontiers in Public Health|September 12, 2022
HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in GermanyM Uhrmacher, A Skaletz-Rorowski, S Nambiar, et al.
Hypertension (Dallas, Tex. : 1979)|November 6, 2013
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient miceSebastian A Potthoff, Michael Fähling, Tilman Clasen, et al.
Pageof 11